Walker & Dunlop, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Walker & Dunlop, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.23B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.13B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.05B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.26B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $1.26B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $1.08B | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $217.19M | Feb 26, 2020 |
| FY2019 | Sep 30, 2019 | $212.27M | Feb 26, 2020 |
| FY2019 | Jun 30, 2019 | $200.33M | Feb 26, 2020 |
| FY2019 | Mar 31, 2019 | $187.44M | Feb 26, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $319.96M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $265.38M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $258.21M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $429.97M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $363.52M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $125.64M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $127.48M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $95.71M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $82.39M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $51.55M | Mar 1, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $56.25M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $108.17M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $107.36M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $213.82M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $265.76M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $246.18M | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $42.92M | Feb 26, 2020 |
| FY2019 | Sep 30, 2019 | $44.04M | Feb 26, 2020 |
| FY2019 | Jun 30, 2019 | $42.20M | Feb 26, 2020 |
| FY2019 | Mar 31, 2019 | $44.22M | Feb 26, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $19.39M | Mar 18, 2013 |
| FY2012 | Sep 30, 2012 | $11.78M | Mar 18, 2013 |
| FY2012 | Jun 30, 2012 | $15.11M | Mar 18, 2013 |
| FY2012 | Mar 31, 2012 | $9.49M | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | $17.93M | Mar 18, 2013 |
| FY2012 | Sep 30, 2011 | $9.65M | Mar 18, 2013 |
| FY2012 | Jun 30, 2011 | $18.22M | Mar 18, 2013 |
| FY2012 | Mar 31, 2011 | $10.87M | Mar 18, 2013 |
| FY2012 | Dec 31, 2010 | $40.14M | Mar 18, 2013 |
| FY2012 | Dec 31, 2009 | $28.60M | Mar 18, 2013 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($664.31M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $129.36M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | ($518.0K) | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.58B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $870.46M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | ($1.41B) | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $427.56M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $64.08M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.07B | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $759.46M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.06B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $4.38B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $4.05B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $4.05B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $5.21B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $4.65B | Feb 23, 2023 |
| FY2020 | Dec 31, 2019 | $2.68B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $2.78B | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $2.21B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $3.05B | Feb 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.31B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.62B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.31B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $2.33B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $3.63B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $3.45B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.63B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $1.87B | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $1.39B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $2.44B | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.74B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.75B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.72B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.69B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.55B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.20B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.04B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $902.12M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $809.42M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $610.22M | Feb 23, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $868.71M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $868.71M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $901.71M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $959.71M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $698.64M | Feb 23, 2023 |
| FY2022 | Dec 31, 2020 | $248.96M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $180.42M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $173.90M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $123.77M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $96.42M | Mar 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.28B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.32B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.30B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.28B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.15B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $952.94M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $796.78M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $666.75M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $579.94M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $381.03M | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $299.32M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $279.27M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $328.70M | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | $225.95M | Feb 26, 2026 |
| FY2024 | Dec 31, 2021 | $305.64M | Feb 25, 2025 |
| FY2023 | Dec 31, 2020 | $321.10M | Feb 22, 2024 |
| FY2022 | Dec 31, 2019 | $120.69M | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | $90.06M | Feb 24, 2022 |
| FY2020 | Dec 31, 2017 | $191.22M | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | $118.76M | Feb 26, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $1.39B | Mar 5, 2015 |
| FY2013 | Dec 31, 2013 | $548.23M | Mar 7, 2014 |
| FY2012 | Dec 31, 2012 | $1.17B | Mar 18, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 8 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 7 | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 26, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 26, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 26, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 26, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 8 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 7 | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 26, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 26, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 26, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 26, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 33.39M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 33.19M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 32.87M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | 32.40M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | 32.05M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 30.68M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | 30.04M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 29.50M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | 30.02M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 29.55M | Feb 23, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $91.80M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $88.63M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $84.84M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $80.15M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $64.45M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $45.35M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $37.27M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $31.45M | Feb 25, 2021 |